PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
6,874,034
Share change
+6,874,034
Total reported value
$21,240,000
Price per share
$3.09
Number of holders
14
Value change
+$21,240,000
Number of buys
14

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q4 2018

As of 31 Dec 2018, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,874,034 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Cormorant Asset Management, LP, Rock Springs Capital Management LP, PRICE T ROWE ASSOCIATES INC /MD/, Alyeska Investment Group, L.P., Vanguard Group Inc, MILLENNIUM MANAGEMENT LLC, CITIGROUP INC, DAFNA Capital Management LLC, and UNITED SERVICES AUTOMOBILE ASSOCIATION. This page lists 14 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.